1256MO Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours
B. Besse, Alexander Drilon, BC Cho, D. Ross Camidge, Joel W. Neal, C-C. Lin, S.V. Liu, M. Nagasaka, S.C-H. Kao, Eudald Felip, Anthonie J. van der Wekken, C.-C. Lin, J.R. Bauman, S. Gadgeel, Manoj Samant, Jiayu Shen, Yun Sun, Viola W. Zhu, Vipul Upadhyay, W. Marston Linehan
Topics & Concepts
MedicineROS1Solid tumorFusionPhase (matter)Cancer researchInternal medicineOncologyAdenocarcinomaCancerLinguisticsChemistryPhilosophyOrganic chemistryMedical Imaging and Pathology StudiesRadiopharmaceutical Chemistry and ApplicationsLung Cancer Treatments and Mutations